428 related articles for article (PubMed ID: 24797264)
1. Identification of small ubiquitin-like modifier substrates with diverse functions using the Xenopus egg extract system.
Ma L; Aslanian A; Sun H; Jin M; Shi Y; Yates JR; Hunter T
Mol Cell Proteomics; 2014 Jul; 13(7):1659-75. PubMed ID: 24797264
[TBL] [Abstract][Full Text] [Related]
2. Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates.
Gocke CB; Yu H; Kang J
J Biol Chem; 2005 Feb; 280(6):5004-12. PubMed ID: 15561718
[TBL] [Abstract][Full Text] [Related]
3. Localization and identification of sumoylated proteins in human sperm: excessive sumoylation is a marker of defective spermatozoa.
Vigodner M; Shrivastava V; Gutstein LE; Schneider J; Nieves E; Goldstein M; Feliciano M; Callaway M
Hum Reprod; 2013 Jan; 28(1):210-23. PubMed ID: 23077236
[TBL] [Abstract][Full Text] [Related]
4. The post-translational modification, SUMOylation, and cancer (Review).
Han ZJ; Feng YH; Gu BH; Li YM; Chen H
Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374
[TBL] [Abstract][Full Text] [Related]
5. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
[TBL] [Abstract][Full Text] [Related]
6. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.
Saito Â; Souza EE; Costa FC; Meirelles GV; Gonçalves KA; Santos MT; Bressan GC; McComb ME; Costello CE; Whelan SA; Kobarg J
J Proteome Res; 2017 Sep; 16(9):3147-3157. PubMed ID: 28695742
[TBL] [Abstract][Full Text] [Related]
7. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.
Gareau JR; Lima CD
Nat Rev Mol Cell Biol; 2010 Dec; 11(12):861-71. PubMed ID: 21102611
[TBL] [Abstract][Full Text] [Related]
8. SUMOylation regulates polo-like kinase 1-interacting checkpoint helicase (PICH) during mitosis.
Sridharan V; Park H; Ryu H; Azuma Y
J Biol Chem; 2015 Feb; 290(6):3269-76. PubMed ID: 25564610
[TBL] [Abstract][Full Text] [Related]
9. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
10. Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.
Impens F; Radoshevich L; Cossart P; Ribet D
Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12432-7. PubMed ID: 25114211
[TBL] [Abstract][Full Text] [Related]
11. Spatiotemporal distribution of SUMOylation components during mouse brain development.
Hasegawa Y; Yoshida D; Nakamura Y; Sakakibara S
J Comp Neurol; 2014 Sep; 522(13):3020-36. PubMed ID: 24639124
[TBL] [Abstract][Full Text] [Related]
12. SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes.
Balasubramaniyan N; Luo Y; Sun AQ; Suchy FJ
J Biol Chem; 2013 May; 288(19):13850-62. PubMed ID: 23546875
[TBL] [Abstract][Full Text] [Related]
13. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
Citro S; Chiocca S
Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
[TBL] [Abstract][Full Text] [Related]
14. Sumoylation of p35 modulates p35/cyclin-dependent kinase (Cdk) 5 complex activity.
Büchner A; Krumova P; Ganesan S; Bähr M; Eckermann K; Weishaupt JH
Neuromolecular Med; 2015 Mar; 17(1):12-23. PubMed ID: 25391294
[TBL] [Abstract][Full Text] [Related]
15. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
[TBL] [Abstract][Full Text] [Related]
16. Converging Small Ubiquitin-like Modifier (SUMO) and Ubiquitin Signaling: Improved Methodology Identifies Co-modified Target Proteins.
Cuijpers SAG; Willemstein E; Vertegaal ACO
Mol Cell Proteomics; 2017 Dec; 16(12):2281-2295. PubMed ID: 28951443
[TBL] [Abstract][Full Text] [Related]
17. Mps1 is SUMO-modified during the cell cycle.
Restuccia A; Yang F; Chen C; Lu L; Dai W
Oncotarget; 2016 Jan; 7(3):3158-70. PubMed ID: 26675261
[TBL] [Abstract][Full Text] [Related]
18. System-wide Analysis of SUMOylation Dynamics in Response to Replication Stress Reveals Novel Small Ubiquitin-like Modified Target Proteins and Acceptor Lysines Relevant for Genome Stability.
Xiao Z; Chang JG; Hendriks IA; Sigurðsson JO; Olsen JV; Vertegaal AC
Mol Cell Proteomics; 2015 May; 14(5):1419-34. PubMed ID: 25755297
[TBL] [Abstract][Full Text] [Related]
19. PIASy mediates SUMO-2/3 conjugation of poly(ADP-ribose) polymerase 1 (PARP1) on mitotic chromosomes.
Ryu H; Al-Ani G; Deckert K; Kirkpatrick D; Gygi SP; Dasso M; Azuma Y
J Biol Chem; 2010 May; 285(19):14415-23. PubMed ID: 20228053
[TBL] [Abstract][Full Text] [Related]
20. Arkadia/RNF111 is a SUMO-targeted ubiquitin ligase with preference for substrates marked with SUMO1-capped SUMO2/3 chain.
Sriramachandran AM; Meyer-Teschendorf K; Pabst S; Ulrich HD; Gehring NH; Hofmann K; Praefcke GJK; Dohmen RJ
Nat Commun; 2019 Aug; 10(1):3678. PubMed ID: 31417085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
